CDx Diagnostics®
Mr. John Watts has more than 30 years of experience in building, growing and leading large health plan organizations. His experience includes leading successful organizations to higher growth targets, through turnaround situations, and building successful new ventures. John also has significant experience in managing P&L for large enterprises.
John spent 12 years at WellPoint, the nation's largest insurer with approximately 35 million members, where he held numerous executive positions, including chief executive and president of Blue Cross Blue Shield of Georgia and president and CEO of National Accounts. In his most recent position as president and CEO of WellPoint's Commercial and Consumer Business, he directed a $50 billion division that encompassed 14 Blue Cross Blue Shield plans.
John is currently on the board of a number of healthcare-related companies including, Blue Cross and Blue Shield of Minnesota, Paradigm Outcomes and Zenith American. In addition, he facilitates roundtable discussions with CEO's from across the healthcare industry as a Managing Director of the Center for Corporate Innovation.
He earned his BA in English from the University of California, Los Angeles (UCLA).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
CDx Diagnostics®
The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods.